NCT02650843Active, not recruiting
Non-motor Symptoms and Brain Dopamine Transporter Binding
Non-motor Symptoms and Brain Dopamine Transporter Binding: An Observational Study in Parkinsonism
Source: ClinicalTrials.gov · Last updated 13 Apr 2025
Brief summary (registry, in English)
This project aims to clarify the role non-motor symptoms in the development of Parkinson's disease (PD) and to improve diagnostics at very early stages of PD. The project involves multidimensional measures of disease biomarkers together with brain dopamine transporter (DAT) imaging with \[123I\]FP-CIT single photon emission computed tomography (SPECT).
- Status (registry)
- Active, not recruiting
- Study type
- Observational
- Enrollment
- 455 (actual)
- First submitted
- 5 Jan 2016
- Start date
- 1 Jan 2015
- Primary completion date
- 31 Dec 2026
- Lead sponsor
- Turku University Hospital
- Diseases
- Parkinson disease
- NCT number
- NCT02650843
What you commit to
- Study type: Observational
- Participants enrolled: 455
- From 1 Jan 2015 to the primary completion date, 31 Dec 2026
- No sites listed in no country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Who the study is looking for
- Male or Female
- Age 18-100 years
- Referred for clinical DAT SPECT in Turku or Helsinki
Age in the registry: 18 years to 100 years · Sex: All · Does not accept healthy volunteers
This page is information, not medical advice. Discuss any trial with your doctor.